#USA #Class Action #New Orleans #Kahn Swick #Organon

Important Alert for Organon Investors

Kahn Swick & Foti, LLC (KSF) has issued a crucial reminder to investors who may have sustained significant financial losses while investing in Organon & Co. (NYSE: OGN). If your losses exceed $100,000 and you acquired securities of Organon during the period from October 31, 2024, to April 30, 2025, you may have a legal claim in a pending class action lawsuit. The deadline to file lead plaintiff applications is fast approaching on July 22, 2025.

Understanding the Context

The lawsuit against Organon accuses the pharmaceutical company and certain of its executives of failing to disclose critical information that would impact shareholder decisions. This legal action arose after the company announced its financial results on March 10, 2025, during pre-market hours. This announcement included a reduction in the company's dividend payout from $0.28 to $0.02—a dramatic shift that contradicted their previous statements about maintaining a strong dividend strategy.

As a result of this unexpected news, Organon's stock price experienced a significant decline of over 27%. Shares plummeted from a closing price of $12.93 on April 30, 2025, to $9.45 the following day. This steep drop has understandably raised alarms among investors, leading to the formation of the class action lawsuit.

What Investors Can Do

For those who purchased Organon securities and are concerned about how this situation may affect their financial standing, KSF encourages you to reach out for further information about your legal rights. The firm is offering consultations without any obligation, which means investors can discuss their potential claims without immediate costs. KSF's Managing Partner, Lewis Kahn, is available for questions via toll-free phone at 1-877-515-1850 or through email at info@ksfcounsel.com. Additionally, more information can be found on their website here.

If you seek to serve as a lead plaintiff in this class action, be advised that you must petition the court by the July 22 deadline.

Lawsuit Background

The case, filed in the United States District Court for the District of New Jersey, is titled Hauser V. Organon & Co., et al., No. 25-cv-05322. It highlights the ongoing challenges that shareholders often face when companies fail to provide accurate and necessary information regarding their financial status and future outlook. Understandably, such cases attract significant attention given the implications for corporate accountability and investor rights.

About Kahn Swick & Foti, LLC

Founded by former Louisiana Attorney General Charles C. Foti, Jr., Kahn Swick & Foti, LLC is recognized as a prominent player in the realm of securities litigation. The firm specializes in assisting both institutional and retail investors in recovering losses stemming from corporate misconduct. With offices strategically located across major U.S. cities and a representative office in Luxembourg, KSF has gained acclaim for its successful track record, ranking among the top ten plaintiff law firms nationally based on settlement values, as reported by SCAS.

To stay informed about your rights as an investor and participate in the ongoing efforts to hold companies accountable, consider taking necessary actions before the approaching deadline. Your rights matter, and legal support is available to guide you through this complex scenario.

Conclusion

Investors impacted by the decline in Organon's share price should not overlook the impending deadline for participation in the class action lawsuit. With legal assistance readily available, taking action could lead to potential recoveries for your losses. Keep in touch with KSF for ongoing updates about the case, and ensure you understand your options as a shareholder in this significant corporate event.